Gene · 6892
Papers1,693
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,693
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α. | Nat Commun | 2022 | 36289205 | PubTator, text mining | PubMed |
| Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021. | Transpl Infect Dis | 2022 | 36271650 | PubTator, text mining | PubMed |
| An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer. | Dis Markers | 2022 | 36267461 | PubTator, text mining | PubMed |
| Crystal structure of the collagen prolyl 4-hydroxylase (C-P4H) catalytic domain complexed with PDI: Toward a model of the C-P4H α2β2 tetramer. | J Biol Chem | 2022 | 36265586 | PubTator, text mining | PubMed |
| Engineering neoantigen vaccines to improve cancer personalized immunotherapy. | Int J Biol Sci | 2022 | 36263174 | PubTator, text mining | PubMed |
| Fast peptide exchange on major histocompatibility complex class I molecules by acidic stabilization of a peptide-empty intermediate. | Protein Sci | 2022 | 36258668 | PubTator, text mining | PubMed |
| Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer. | Front Oncol | 2022 | 36248998 | PubTator, text mining | PubMed |
| PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types. | Front Immunol | 2022 | 36248841 | PubTator, text mining | PubMed |
| The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma. | Clin Transl Med | 2022 | 36245289 | PubTator, text mining | PubMed |
| Pharmacogenetic Variation and Its Clinical Relevance in a Latin American Rural Population. | Int J Mol Sci | 2022 | 36233078 | PubTator, text mining | PubMed |
| Proteomic Profiling Skin Mucus of European Eel Anguilla anguilla Infected with Anguillid Herpesvirus. | Int J Mol Sci | 2022 | 36232585 | PubTator, text mining | PubMed |
| Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence. | Cells | 2022 | 36230929 | PubTator, text mining | PubMed |
| PRELP Regulates Cell-Cell Adhesion and EMT and Inhibits Retinoblastoma Progression. | Cancers (Basel) | 2022 | 36230849 | PubTator, text mining | PubMed |
| Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer. | Am J Cancer Res | 2022 | 36225631 | PubTator, text mining | PubMed |
| PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer. | Cancer Res | 2022 | 36222718 | PubTator, text mining | PubMed |
| The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC-II molecules. | EMBO Rep | 2022 | 36215666 | PubTator, text mining | PubMed |
| Tetraspanin-5-mediated MHC class I clustering is required for optimal CD8 T cell activation. | Proc Natl Acad Sci U S A | 2022 | 36215490 | PubTator, text mining | PubMed |
| Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis. | Front Immunol | 2022 | 36211383 | PubTator, text mining | PubMed |
| The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells. | Mol Biol Rep | 2022 | 36207500 | PubTator, text mining | PubMed |
| T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis. | Curr Rheumatol Rep | 2022 | 36197645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6892/papers?page=14